Avondale Pharmaceuticals, LLC signs development agreement with Oxford Pharmaceuticals, LLC
BIRMINGHAM, Ala., July 17, 2018 /PRNewswire/ — Avondale Pharmaceuticals, LLC, announced today an exclusive, product development partnership with Oxford Pharmaceuticals, a pharmaceutical manufacturer and distributor based in Birmingham, AL. John Schultz, President of Oxford said “Oxford is extremely pleased to continue its relationship with Avondale through this partnership to advance the capabilities and experience of the Oxford staff providing high quality products. The partnership will enable Avondale to continue to bring unique and high-quality drug products to market for patients across the U.S.”
About Oxford Pharmaceuticals, LLC
Oxford Pharmaceuticals is a manufacturer and distributor of generic pharmaceutical products with a new state of the art manufacturing facility. Oxford’s capabilities include drug development, contract manufacturing, and packaging including serialization.
About Avondale Pharmaceuticals, LLC
Avondale is an innovative U.S. distributor of specialty branded pharmaceutical products across several therapeutic categories. Avondale specializes in identifying and bringing to market quality, affordable products to customers and patients.
For additional information please contact Avondale at 800-528-3058 or visit www.avondalepharm.com.
123 West Main Street
Birmingham, AL 12345
To report suspected adverse reactions, contact Avondale Pharmaceuticals at (800) 528-3058